Searchable abstracts of presentations at key conferences in endocrinology

ea0026s4.1 | Subclinical hormone excess | ECE2011

Subclinical adrenal hyperfunction

Kaltsas G

The adrenal glands secrete a variety of hormones from the cortex (steroids) and the medulla (amines) that when in excess lead to characteristic clinical syndromes. Dysregulation of the secretory pattern of these hormones or hypersecretion not enough to cause a clinically obvious syndrome is termed subclinical hyperfunction and is mainly found in primary adrenal lesions in the form of adrenal incidentalomas (AI). These are adrenal mass lesions usually >1 cm in diameter that...

ea0026s24.1 | Management of phaechromocytoma | ECE2011

Biochemical screening for phaeochromocytoma using plasma free metanephrines: utility beyond diagnosis

Eisenhofer G

Measurements of plasma concentrations of the O-methylated metabolites of catecholamines including metanephrine, normetanephrine and methoxytyramine have advantages over other biochemical tests used to diagnose phaeochromocytoma for several reasons: i) the metabolites are produced within chromaffin cells continuously from catecholamines leaking from storage vesicles; ii) the single largest source of these metabolites is from adrenal medullary chromaffin cells, but this p...

ea0026s25.1 | GNAS locus: imprinting, animal models and human diseases | ECE2011

Genomic imprinting of the GNAS locus

Kelsey G

Genomic imprinting is an epigenetic mechanism by which a subset of our genes displays unequal expression of the maternal and paternal alleles; in many cases, one allele is fully silenced. It occurs because these genes are marked differently (by DNA methylation and/or histone modifications) in male and female gametes. These gamete-specific marks are maintained at fertilisation and perpetuated throughout development and adult life, such that the alleles of imprinted genes retain...

ea0026s26.1 | The role of plasma binding proteins in tissue hormone delivery | ECE2011

Sex hormone-binding globulin: beyond plasma transport

Hammond G

Sex hormone-binding globulin (SHBG) transports sex steroids (androgens and estrogens) in the blood and regulates their access to tissues. In humans and other vertebrates, the liver produces the SHBG that circulates in the blood, and in most species the gene encoding SHBG is also expressed in the testis. The testicular cell types in which SHBG is produced vary between species; in most mammals, expression of the Shbg gene in Sertoli cells gives rise to a secreted protein ...

ea0020s12.4 | Growth factors and signaling networks in pituitary tumours | ECE2009

Predictive markers of pituitary adenoma behaviour

Kontogeorgos G

Markers to predict tumor biology represent an important tool for the optimal management of pituitary adenomas. Specific morphologic features may serve as predictive markers of tumor behavior. These include a) tumor cell-specific markers, b) stromal-related elements involving vasculature and angiogenetic factors, and additional stromal substances and c) miscellaneous tumor type-associated features.Macroscopic invasion of the perisellar tissues, defined as...

ea0019s20 | What's Wnt? A novel signalling pathway in endocrinology | SFEBES2009

Defects in Wnt signalling in hyperparathyroidism

Westin G

Wnt ligands are secreted proteins that bind to Frizzled receptors. During normal development Wnt signalling plays essential roles in the regulation of patterning, fate determination, and cell proliferation. In the ‘canonical’ Wnt/ß-catenin signalling pathway, binding of Wnt ligand to Frizzled and LRP5 receptors normally leads to inhibition of a ‘destruction complex’ consisting of APC/Axin/GSK-3ß/Ck1/Dvl and other factors, with subsequent accumulat...